Correlation Between BioNTech and Entero Therapeutics,

Can any of the company-specific risk be diversified away by investing in both BioNTech and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BioNTech SE and Entero Therapeutics,, you can compare the effects of market volatilities on BioNTech and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Entero Therapeutics,.

Diversification Opportunities for BioNTech and Entero Therapeutics,

0.1

Correlation Coefficient

BioNTech  Entero Therapeutics,

Average diversification

The 3 months correlation between BioNTech and Entero is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of BioNTech i.e., BioNTech and Entero Therapeutics, go up and down completely randomly.

Pair Corralation between BioNTech and Entero Therapeutics,

Given the investment horizon of 90 days BioNTech SE is expected to under-perform the Entero Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, BioNTech SE is 1.93 times less risky than Entero Therapeutics,. The stock trades about -0.05 of its potential returns per unit of risk. The Entero Therapeutics, is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  63.00  in Entero Therapeutics, on December 20, 2024 and sell it today you would lose (10.00) from holding Entero Therapeutics, or give up 15.87% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

BioNTech SE  vs.  Entero Therapeutics,

BioNTech SE

Risk-Adjusted Performance

Very Weak

Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Entero Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Entero Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with BioNTech and Entero Therapeutics,

The main advantage of trading using opposite BioNTech and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.

The idea behind BioNTech SE and Entero Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.